Literature DB >> 16758519

Mutations in Helicobacter pylori porD and oorD genes may contribute to furazolidone resistance.

Zhaoliang Su1, Huaxi Xu, Chiyu Zhang, Shihe Shao, Liangju Li, Hua Wang, Huifang Wang, Gufeng Qiu.   

Abstract

AIM: To determine the rate of furazolidone resistance of Helicobacter pylori (H. pylori) isolated from gastric biopsy specimens and to explore the relationship between genetic mutations in porD and oorD genes of H. pylori and its resistance to the antibiotic.
METHODS: Gastric biopsy was performed in 83 adult patients aged 31-77 years with gastric complaints. H. pylori was isolated from biopsy specimens of 46 patients. E-test and 2-fold agar dilution method were used to determine the rate of H. pylori resistance to furazolidone. The genes porD and oorD from susceptible and resistant isolates were amplified by polymerase chain reaction (PCR), and their PCR products were sequenced.
RESULTS: Resistance to furazolidone was found in 8.7% of H. pylori isolates and 6 mutations were detected in porD and oorD genes of the resistant isolates. Three mutations--G353A, A356G, and C357T--occurred in porD and the other mutations--A041G, A122G, C349A(G)--occurred in oorD genes.
CONCLUSIONS: Changes in 6 amino acids may be associated with the resistance of H. pylori to furazolidone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16758519      PMCID: PMC2080422     

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  20 in total

Review 1.  Helicobacter pylori infection.

Authors:  Sebastian Suerbaum; Pierre Michetti
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

2.  Ancient genes in contemporary persistent microbial pathogens.

Authors:  Vijayasarathy Srinivasan; Harold J Morowitz
Journal:  Biol Bull       Date:  2006-02       Impact factor: 1.818

Review 3.  Helicobacter pylori: current chemotherapy and new targets for drug design.

Authors:  J S Williamson
Journal:  Curr Pharm Des       Date:  2001-03       Impact factor: 3.116

4.  The Entner-Doudoroff pathway has little effect on Helicobacter pylori colonization of mice.

Authors:  Amy E Wanken; Tyrrell Conway; Kathryn A Eaton
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

5.  Quantitative structure-activity relationships in two-electron reduction of nitroaromatic compounds by Enterobacter cloacae NAD(P)H:nitroreductase.

Authors:  H Nivinskas; R L Koder; Z Anusevicius; J Sarlauskas; A F Miller; N Cenas
Journal:  Arch Biochem Biophys       Date:  2001-01-01       Impact factor: 4.013

6.  Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori.

Authors:  D H Kwon; F A El-Zaatari; M Kato; M S Osato; R Reddy; Y Yamaoka; D Y Graham
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

7.  Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance.

Authors:  D H Kwon; M Lee; J J Kim; J G Kim; F A El-Zaatari; M S Osato; D Y Graham
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

8.  Nitazoxanide in treatment of Helicobacter pylori: a clinical and in vitro study.

Authors:  Yvonne Guttner; Helen M Windsor; Charlie H Viiala; Leon Dusci; Barry J Marshall
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

9.  The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections.

Authors:  Brian J McMahon; Thomas W Hennessy; J Michael Bensler; Dana L Bruden; Alan J Parkinson; Julie M Morris; Alisa L Reasonover; Debby A Hurlburt; Michael G Bruce; Frank Sacco; Jay C Butler
Journal:  Ann Intern Med       Date:  2003-09-16       Impact factor: 25.391

10.  Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori.

Authors:  Gary Sisson; Avery Goodwin; Ausra Raudonikiene; Nicky J Hughes; Asish K Mukhopadhyay; Douglas E Berg; Paul S Hoffman
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

View more
  10 in total

Review 1.  Primary Antibiotic Resistance of Helicobacter pylori in China.

Authors:  Yi Hu; Yin Zhu; Nong-Hua Lu
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

Review 2.  Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Clin Microbiol Rev       Date:  2022-04-11       Impact factor: 50.129

3.  The rag locus of Porphyromonas gingivalis might arise from Bacteroides via horizontal gene transfer.

Authors:  Z Su; F Kong; S Wang; J Chen; R Yin; C Zhou; Y Zhang; Z He; Y Shi; Y Xue; X Shi; L Lu; Q Shao; H Xu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-02       Impact factor: 3.267

4.  Four novel resistance integron gene-cassette occurrences in bacterial isolates from zhenjiang, china.

Authors:  Huaxi Xu; Zhaoliang Su; Shengjun Wang; Xiaoli Dai; Jianguo Chen; Fanzhi Kong; Yazhen Li; Sufang Peng; Qixiang Shao; Liwei Lu; T Ezaki
Journal:  Curr Microbiol       Date:  2009-04-14       Impact factor: 2.188

Review 5.  Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis.

Authors:  Angelo Zullo; Enzo Ierardi; Cesare Hassan; Vincenzo De Francesco
Journal:  Saudi J Gastroenterol       Date:  2012 Jan-Feb       Impact factor: 2.485

6.  Resistance of Helicobacter pylori to furazolidone and levofloxacin: A viewpoint.

Authors:  Mohammad Zamani; Arash Rahbar; Javad Shokri-Shirvani
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

Review 7.  Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.

Authors:  Yi Hu; Yin Zhu; Nong-Hua Lu
Journal:  Front Cell Infect Microbiol       Date:  2017-05-05       Impact factor: 5.293

8.  The Involvement of the Cas9 Gene in Virulence of Campylobacter jejuni.

Authors:  Muhammad A B Shabbir; Yanping Tang; Zihui Xu; Mingyue Lin; Guyue Cheng; Menghong Dai; Xu Wang; Zhengli Liu; Zonghui Yuan; Haihong Hao
Journal:  Front Cell Infect Microbiol       Date:  2018-08-20       Impact factor: 5.293

9.  Safety of furazolidone-containing regimen in Helicobacter pylori infection: a systematic review and meta-analysis.

Authors:  Chao-Ran Ji; Jing Liu; Yue-Yue Li; Chuan-Guo Guo; Jun-Yan Qu; Yan Zhang; Xiuli Zuo
Journal:  BMJ Open       Date:  2020-10-19       Impact factor: 2.692

10.  Multiple Genetic Analysis System-Based Antibiotic Susceptibility Testing in Helicobacter pylori and High Eradication Rate With Phenotypic Resistance-Guided Quadruple Therapy.

Authors:  Fangyuan Dong; Danian Ji; Renxiang Huang; Fan Zhang; Yiqin Huang; Ping Xiang; Mimi Kong; Li Nan; Xianping Zeng; Yong Wu; Zhijun Bao
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.